KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueDepreciation & Amortization - TotalEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRestructuring CostsRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Liveperson (LPSN) EBITDA (2016 - 2025)

Historic EBITDA for Liveperson (LPSN) over the last 17 years, with Q3 2025 value amounting to -$9.1 million.

  • Liveperson's EBITDA fell 399.4% to -$9.1 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$122.3 million, marking a year-over-year decrease of 2269.36%. This contributed to the annual value of -$183.2 million for FY2024, which is 6448.48% down from last year.
  • As of Q3 2025, Liveperson's EBITDA stood at -$9.1 million, which was down 399.4% from -$833000.0 recorded in Q2 2025.
  • In the past 5 years, Liveperson's EBITDA ranged from a high of $5.6 million in Q2 2023 and a low of -$101.0 million during Q4 2024
  • Over the past 5 years, Liveperson's median EBITDA value was -$25.1 million (recorded in 2024), while the average stood at -$32.0 million.
  • Per our database at Business Quant, Liveperson's EBITDA crashed by 57875.88% in 2021 and then soared by 10802.57% in 2023.
  • Liveperson's EBITDA (Quarter) stood at -$45.3 million in 2021, then increased by 14.01% to -$38.9 million in 2022, then dropped by 4.45% to -$40.7 million in 2023, then plummeted by 148.33% to -$101.0 million in 2024, then skyrocketed by 91.0% to -$9.1 million in 2025.
  • Its EBITDA was -$9.1 million in Q3 2025, compared to -$833000.0 in Q2 2025 and -$11.3 million in Q1 2025.